STAAR SURGICAL CO (STAA)
US8523123052 - Common Stock
Staar Surgical Enters Oversold Territory (STAA)
STAAR Surgical to Participate in Stephens Annual Investment Conference (NASH2024)
In the world of growth stocks, NASDAQ:STAA shines as a value proposition.
Investors should take note of NASDAQ:STAA, a growth stock that remains attractively priced.
CORRECTING and REPLACING STAAR Surgical Reports Third Quarter 2024 Results
STAAR Surgical to Report Third Quarter Results on October 30, 2024
STAAR Surgical Experience Center Expands to Meet Growing Surgeon Demand
Sidoti Events, LLC's Virtual September Small-Cap Conference
Staar Surgical Enters Oversold Territory (STAA)
Commit To Purchase Staar Surgical Co. At $30, Earn 13.3% Annualized Using Options
STAA Stock Earnings: Staar Surgical Misses EPS, Beats Revenue for Q2 2024
STAA stock results show that Staar Surgical missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
STAA Stock Earnings: Staar Surgical Misses EPS, Beats Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Staar Surgical (NASDAQ:STAA) just reported results for the second quarter of 20...
STAAR Surgical Reports Second Quarter 2024 Results
STAAR Surgical to Report Second Quarter Results on August 7, 2024
STAAR Surgical to Participate in Canaccord Genuity 44th Annual Growth Conference
Staar Surgical Stock Earns RS Rating Upgrade
On Thursday, lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 87 from 77.
Notable Wednesday Option Activity: STAA, SVRA, B
STAA Makes Notable Cross Below Critical Moving Average
STAAR Surgical to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
Oversold Conditions For Staar Surgical (STAA)
STAA Stock Earnings: Staar Surgical Misses EPS, Beats Revenue for Q1 2024
STAA stock results show that Staar Surgical missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
STAA Stock Earnings: Staar Surgical Misses EPS, Beats Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Staar Surgical (NASDAQ:STAA) just reported results for the first quarter of 202...
STAAR Surgical Reports First Quarter 2024 Results
STAAR Surgical Announces Milestone Strategic Agreement in U.S. with IQ Laser Vision
STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel
STAAR Surgical to Report First Quarter Results on May 7, 2024
Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Rating
On Thursday, implantable lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 84, up from 80 a day earlier.